We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Healthcare 11.34%
3 Financials 9.38%
4 Consumer Discretionary 8.31%
5 Communication Services 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRAK icon
6476
ReposiTrak
TRAK
$158M
$24K ﹤0.01%
4,437
+84
+2% +$457
VTGN icon
6477
VistaGen Therapeutics
VTGN
$11.8M
$24K ﹤0.01%
5,163
+833
+19% +$8.26K
WBX.WS
6478
DELISTED
Wallbox N.V. Warrants, each warrant to purchase one Class A Ordinary Share
WBX.WS
$24K ﹤0.01%
+17,500
New +$32.8K
AUUD
6479
Auddia
AUUD
$5.47M
$23K ﹤0.01%
5
CRBP icon
6480
Corbus Pharmaceuticals
CRBP
$195M
$23K ﹤0.01%
4,828
+367
+8% +$2.59K
DEEP icon
6481
Acquirers Small and Micro Deep Value ETF
DEEP
$28.4M
$23K ﹤0.01%
823
-300
-27% -$9.39K
EMTY icon
6482
ProShares Decline of the Retail Store ETF
EMTY
$2.89M
$23K ﹤0.01%
688
+593
+624% +$18.5K
FBCG
6483
Fidelity Blue Chip Growth ETF
FBCG
$7.34B
$23K ﹤0.01%
1,090
-21,087
-95% -$506K
GINN icon
6484
Goldman Sachs Innovate Equity ETF
GINN
$215M
$23K ﹤0.01%
581
-130
-18% -$5.73K
HAUZ icon
6485
Xtrackers International Real Estate ETF
HAUZ
$1.07B
$23K ﹤0.01%
1,172
-10
-0.8% -$221
IDR icon
6486
Idaho Strategic Resources
IDR
$500M
$23K ﹤0.01%
4,893
KALA icon
6487
KALA BIO
KALA
$17.9M
$23K ﹤0.01%
41
-8
-16% -$6.28K
LVTX
6488
DELISTED
LAVA Therapeutics
LVTX
$23K ﹤0.01%
5,000
-700
-12% -$1.93K
KG
6489
Kestrel Group
KG
$60.5M
$23K ﹤0.01%
522
-1,846
-78% -$78.5K
NVVE
6490
DELISTED
Nuvve Holding Corp
NVVE
0
OTRK
6491
DELISTED
Ontrak
OTRK
$23K ﹤0.01%
540
+74
+16% +$5.18K
PJUL icon
6492
Innovator US Equity Power Buffer ETF July
PJUL
$1.29B
$23K ﹤0.01%
+799
New +$24.1K
PXS icon
6493
Pyxis Tankers
PXS
$52.5M
$23K ﹤0.01%
6,000
UONE icon
6494
Urban One Class A
UONE
$23.5M
$23K ﹤0.01%
428
+75
+21% +$4.2K
VFMV icon
6495
Vanguard US Minimum Volatility ETF
VFMV
$446M
$23K ﹤0.01%
260
-61
-19% -$5.97K
VOTE icon
6496
TCW Transform 500 ETF
VOTE
$1.15B
$23K ﹤0.01%
547
+537
+5,370% +$24.8K
SALM
6497
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$23K ﹤0.01%
13,043
-19,913
-60% -$43.5K
BSQR
6498
DELISTED
BSQUARE Corporation
BSQR
$23K ﹤0.01%
20,013
-46,219
-70% -$59K
CTMX icon
6499
CytomX Therapeutics
CTMX
$730M
$22K ﹤0.01%
15,053
-146,368
-91% -$225K
DNTH icon
6500
Dianthus Therapeutics
DNTH
$6.13B
$22K ﹤0.01%
963
-900
-48% -$24.6K

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.